Eric Simpson, M.D., M.C.R.

Eric Simpson, M.D., M.C.R., is a Professor of Medical Dermatology at Oregon Health & Science University. His research focuses on the clinical management of atopic dermatitis, including pediatric allergy, skin barrier dysfunction, and the evaluation of novel systemic and topical therapies for moderate-to-severe disease. His recent work includes phase 3 trials of rocatinlimab and roflumilast cream, long-term safety analyses of abrocitinib, and studies on emollient-based prevention of pediatric eczema. He has also investigated treatment sequencing, such as switching from dupilumab to abrocitinib, and the impact of therapies on patient sleep outcomes.